Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Industry Balks At Deadline For New Manufacturing Volume Reporting Requirements
Jan 12 2022
•
By
Shannon Brown
Time is running out before FDA requires CARES Act manufacturing reporting • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance